Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY162016-06-30 | Q1 FY162016-03-31 | Q4 FY152015-12-31 | Q3 FY152015-09-30 | Q2 FY152015-06-30 | Q1 FY152015-03-31 | Q4 FY142014-12-31 | Q3 FY142014-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.68B | $11.81B | $12.80B | $12.49B | $12.90B | $12.20B | $13.35B | $13.30B |
| Cost of revenue | $4.45B | $4.21B | $4.55B | $4.39B | $4.49B | $3.98B | $4.42B | $4.42B |
| Gross profit | $8.23B | $7.60B | $8.26B | $8.10B | $8.41B | $8.22B | $8.94B | $8.88B |
| Gross margin | 64.9% | 64.3% | 64.5% | 64.9% | 65.2% | 67.4% | 66.9% | 66.8% |
| Research and development | $2.19B | $2.04B | $2.47B | $2.19B | $2.21B | $2.07B | $2.54B | $2.16B |
| Selling, general and administrative | $3.65B | $3.31B | $3.89B | $3.46B | $3.62B | $3.28B | $3.97B | $3.57B |
| Operating expenses | $6.37B | $5.35B | $6.36B | $5.65B | $6.49B | $5.35B | $6.50B | $5.73B |
| Operating income | $1.85B | $2.25B | $1.90B | $2.44B | $1.92B | $2.87B | $2.44B | $3.15B |
| Operating margin | 14.6% | 19.1% | 14.8% | 19.6% | 14.9% | 23.5% | 18.2% | 23.7% |
| EBITDA | $3.32B | $3.62B | $1.90B | $3.80B | $3.43B | $4.16B | $2.44B | $4.32B |
| Interest expense | −$180.00M | −$185.00M | −$158.00M | −$154.00M | −$164.00M | −$179.00M | −$188.00M | −$182.00M |
| Income before taxes | $2.11B | $2.35B | $1.13B | $2.17B | $2.16B | $2.68B | $2.76B | $3.53B |
| Income taxes | $307.00M | $341.00M | $77.00M | $357.00M | $300.00M | $372.00M | $308.00M | $430.00M |
| Net income | $1.81B | $2.01B | $1.06B | $1.90B | $1.84B | $13.01B | $1.49B | $3.24B |
| Net margin | 14.2% | 17.0% | 8.2% | 15.2% | 14.3% | 106.6% | 11.1% | 24.4% |
| EPS, basic | $0.76 | $0.85 | $0.46 | $0.79 | $0.76 | $5.40 | $0.63 | $1.33 |
| EPS, diluted | $0.75 | $0.84 | $0.45 | $0.77 | $0.75 | $5.32 | $0.61 | $1.31 |
| Diluted shares | 2.40B | 2.40B | 2.44B | 2.44B | 2.45B | 2.45B | 2.47B | 2.46B |
Figures describe Novartis AG shares, not any token. As of Feb 4, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.